Dogwood Therapeutics, Inc. (DWTX) › Cash & EquivalentsDogwood Therapeutics, Inc. (DWTX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $29.80M2021-12-31: $14.01M2022-12-31: $7.03M2023-12-31: $3.32M2024-12-31: $14.85M2025-12-31: $6.52M$6.52M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$6.52M-56.1%2026-03-18Balance as of period end2024-12-31$14.85M+347.6%2026-03-18Balance as of period end2023-12-31$3.32M-52.8%2025-03-31Balance as of period end2022-12-31$7.03M-49.8%2024-03-08Balance as of period end2021-12-31$14.01M-53.0%2023-03-14Balance as of period end2020-12-31$29.80M—2022-03-18Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)